 |
|
|
| |
GSK2336805 HCV NS5A Inhibitor Demonstrates Potent Antiviral Activity in Chronic Hepatitis C (CHC) Genotype 1 Infection: Results from a First Time in Human (FTIH) Single and Repeat Dose Study
|
| |
| |
Reported by Jules Levin AASLD Nov 5-9 2011 SF
W Spreen1, D Wilfret1, J Bechtel1, K Adkison1, Y Lou1, L Jones1, S Willsie2, S Glass3, C Roberts1 1. Research and Development, GlaxoSmithKline, Research Triangle Park, NC, 2. PRA International, Lenexa, KS, 3. CRI Worldwide, Willingboro, NJ
|
| |
|
|
|
|
|
